Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Scientific Reports|July 27, 2017
Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A 2A adenosine receptor binding sitePierre Matricon, Anirudh Ranganathan, Eugene Warnick, et al.
Journal of Psychopharmacology (Oxford, England)|June 5, 2019
Regulation of adenosine A2A receptor gene expression in a model of binge eating in the amygdaloid complex of female ratsMaria Vittoria Micioni Di Bonaventura, Mariangela Pucci, Maria Elena Giusepponi, et al.
Cells|June 25, 2020
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of ColitisLuca Antonioli, Elena Lucarini, Catia Lambertucci, et al.
The Journal of Pharmacy and Pharmacology|April 29, 2014
Pharmacological postconditioning of the rabbit heart with non-selective, A1 , A2A and A3 adenosine receptor agonistsSophia-Iris Bibli, Efstathios K Iliodromitis, Catia Lambertucci, et al.
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 DeltaSara Calenda, Daniela Catarzi, Flavia Varano, et al.
Molecules (Basel, Switzerland)|April 23, 2022
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?Andrea Spinaci, Catia Lambertucci, Michela Buccioni, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 12, 2026
Synthesis and characterization of new P2X7 receptor antagonists as antitumor agentsMarianna Grignolo, Andrea Spinaci, Ludovica Ricci, et al.
FEBS Open Bio|April 4, 2025
Adenosine A3 receptor antagonists as anti-tumor treatment in human prostate cancer: an in vitro studyMaria Beatrice Morelli, Andrea Spinaci, Cui Chang, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 12, 2025
A2A receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatmentAkshaya Murugesan, Aleksei Smirnov, Anxo Vila Alonso, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
"Dual Anta-Inhibitors" of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling StudiesAndrea Spinaci, Michela Buccioni, Daniela Catarzi, et al.
Pageof 10